Novel approaches are needed to address the general wellbeing of patients with cancer. Studies presented at #ESMO25 add to growing evidence supporting the use of #DigitalTools.
Find out more in the #ESMODailyReporter 👉 https://ow.ly/uSpY50XjC7Q

#CancerCare #DigitalHealth

@paoli-calmettes.bsky.social célèbre un siècle d’activités de soins, de recherches et de formations par une série de conférences thématiques. Le 5 Novembre venez écouter comment les innovations diagnostiques et thérapeutiques sont développées et mises en œuvre dans le domaine de l’onco-hématologie

@paoli-calmettes.bsky.social celebrates a century of intermingled care, research and éducation for the benefit of patients in Southeastern France. On Nov 5th, listen to a string of présentations depicting progress in Hematology and how diagnostic and therapeutic innovations are being implemented

Honoured to speak today along with #ACTO2025 the 16th #ACTO Annual Meeting in Singapore. Describing the #GoCART Coalition vision, mission & activities to foster the development and access to #CART Cells therapies in Europe @theebmt.bsky.social

New approach enables body to engineer its own cells to fight cancer or autoimmunity Injections of mRNA may offer a simpler, cheaper way to build powerful CAR-T cells

New approach enables body to engineer its own cells to fight cancer or autoimmunity | Science | AAAS www.science.org/content/arti...

Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma | NEJM Measurable residual disease (MRD) is a major prognostic factor in newly diagnosed multiple myeloma. An assessment of an MRD-guided consolidation strategy in patients who are eligible for autologous...

Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma | New England Journal of Medicine www.nejm.org/doi/full/10....

Through deep financial cuts and restrictions on #research, the first 100 days of the Trump administration led to the upheaval of the U.S. #biomedical infrastructure. Below, #hematologists share how these policies are affecting the future of #patient care: ow.ly/4lGK50VY4V6
#HemeSky #MedSky

Research may be increasingly incremental—but studies making lasting paradigm shifts are on the rise New metric identifying “persistently disruptive” papers offers a “bright spot” amid signs of declining innovation

Research may be increasingly incremental—but studies making lasting paradigm shifts are on the rise | Science | AAAS www.science.org/content/arti...

European cancer mortality predictions for the year 2025 with focus on breast cancer We predicted the number of cancer deaths and rates for 2025 in the European Union (EU), its five most populous countries, and the UK, focusing on breast cancer.

European cancer mortality predictions for the year 2025 with focus on breast cancer - Annals of Oncology www.annalsofoncology.org/article/S092...
Cannot resist sharing good news!

Distinct adipose progenitor cells emerging with age drive active adipogenesis Starting at middle age, adults often suffer from visceral adiposity and associated adverse metabolic disorders. Lineage tracing in mice revealed that adipose progenitor cells (APCs) in visceral fat un...

Distinct adipose progenitor cells emerging with age drive active adipogenesis | Science www.science.org/doi/10.1126/...

🕵️‍♀️ In this cancer Clue game:
🧬 Victim: CSCs
🔪 Weapon: Nifuroxazide
🎯 Mode: DNA crosslinks + STAT3 block
🧬 Scene: PARPi-resistant breast cancer

From the Charafe/Ginestier team @CRCM
🔗 pubmed.ncbi.nlm.nih.gov/40038300/

✍️ by @celiarouault.bsky.social
🔗 communities.springernature.com/posts/unveil...

I am thrilled to share my first paper published in @naturecomms.bsky.social, Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARPi in breast cancer @Christophe Ginestier @emmanuellecharafe.bsky.social I thanks all the collaborators and supporters
rdcu.be/ecaao

Félicitations au Pr. @ericvivier.bsky.social, du Centre d’Immunologie de Marseille-Luminy, lauréat du Prix ARC Léopold Griffuel ! Une belle reconnaissance pour ses avancées majeures en immunothérapie 🔬👏

#Recherche #Immunologie #AMU #ExcellenceScientifique

Longest human transplant of pig kidney fails In latest xenotransplant test, Towana Looney’s body rejects gene-edited organ after more than 4 months

Longest human transplant of pig kidney fails | Science | AAAS www.science.org/content/arti...

🚀 Lancement de l’Appel à Manifestation d'Intérêt (AMI) Immunologie d’Amidex !

Ce programme met en relation les projets académiques du site d'Aix-Marseille avec les plateformes de pointe BScreen et CellScale, intégrées au Marseille Immunology Biocluster.

👉+d'infos : www.univ-amu.fr/fr/public/ac...

The New EU CAR-T Handbook: All the Latest in CAR-T YouTube video by WebsEdgeMedicine

Editor-in-chief @chadoc13.bsky.social discusses the 2nd edition of the EU CAR-T Handbook, highlighting key updates, emerging innovations & how it supports transplant professionals in delivering advanced cellular treatments. #EBMT25 youtu.be/MwYwDJfzKus